Bloomage Biotechnology Corp Ltd
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature nam… Read more
Bloomage Biotechnology Corp Ltd (688363) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.013x
Based on the latest financial reports, Bloomage Biotechnology Corp Ltd (688363) has a cash flow conversion efficiency ratio of 0.013x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥93.75 Million) by net assets (CN¥7.09 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bloomage Biotechnology Corp Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Bloomage Biotechnology Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bloomage Biotechnology Corp Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bloomage Biotechnology Corp Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hangzhou Zhongheng Electric Co Ltd
SHE:002364
|
-0.005x |
|
Cementos Argos S.A.
SN:CEMARGOSCL
|
N/A |
|
Wuxi Rural Commercial Bank Co Ltd
SHG:600908
|
-0.059x |
|
MakeMyTrip Limited
NASDAQ:MMYT
|
-0.163x |
|
Mando Corp
KO:204320
|
0.109x |
|
Net263 Ltd
SHE:002467
|
0.014x |
|
Tennant Company
NYSE:TNC
|
0.045x |
|
Pexa Group Ltd
AU:PXA
|
0.053x |
Annual Cash Flow Conversion Efficiency for Bloomage Biotechnology Corp Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Bloomage Biotechnology Corp Ltd from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥6.84 Billion | CN¥564.51 Million | 0.083x | -17.62% |
| 2023-12-31 | CN¥6.98 Billion | CN¥699.65 Million | 0.100x | +5.41% |
| 2022-12-31 | CN¥6.68 Billion | CN¥635.19 Million | 0.095x | -57.53% |
| 2021-12-31 | CN¥5.70 Billion | CN¥1.28 Billion | 0.224x | +61.67% |
| 2020-12-31 | CN¥5.09 Billion | CN¥705.12 Million | 0.138x | +72.58% |
| 2019-12-31 | CN¥4.55 Billion | CN¥364.89 Million | 0.080x | -68.86% |
| 2018-12-31 | CN¥1.72 Billion | CN¥442.30 Million | 0.258x | +22.81% |
| 2017-12-31 | CN¥1.64 Billion | CN¥343.42 Million | 0.210x | +9.39% |
| 2016-12-31 | CN¥1.26 Billion | CN¥241.68 Million | 0.192x | +56.87% |
| 2015-12-31 | CN¥1.19 Billion | CN¥145.67 Million | 0.122x | -33.10% |
| 2014-12-31 | CN¥752.51 Million | CN¥137.47 Million | 0.183x | -33.62% |
| 2013-12-31 | CN¥564.35 Million | CN¥155.33 Million | 0.275x | +24.08% |
| 2012-12-31 | CN¥376.97 Million | CN¥83.62 Million | 0.222x | -- |